Cholesterol efflux capacity as a therapeutic target rationale and clinical implications

Research output: Contribution to journalArticle

9 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)2211-2213
Number of pages3
JournalJournal of the American College of Cardiology
Volume66
Issue number20
DOIs
StatePublished - Nov 17 2015

Fingerprint

Pre-beta High-Density Lipoprotein
Anticholesteremic Agents
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Dyslipidemias
Benzodiazepines
Cholesterol
Therapeutics

Keywords

  • ABAC1
  • CETP
  • cholesterol efflux
  • HDL functionality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{61be41cc6c7442b3b79458a77ebbf3c4,
title = "Cholesterol efflux capacity as a therapeutic target rationale and clinical implications",
keywords = "ABAC1, CETP, cholesterol efflux, HDL functionality",
author = "Rohatgi, {Anand K} and Grundy, {Scott M}",
year = "2015",
month = "11",
day = "17",
doi = "10.1016/j.jacc.2015.09.012",
language = "English (US)",
volume = "66",
pages = "2211--2213",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "20",

}

TY - JOUR

T1 - Cholesterol efflux capacity as a therapeutic target rationale and clinical implications

AU - Rohatgi, Anand K

AU - Grundy, Scott M

PY - 2015/11/17

Y1 - 2015/11/17

KW - ABAC1

KW - CETP

KW - cholesterol efflux

KW - HDL functionality

UR - http://www.scopus.com/inward/record.url?scp=84946748049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946748049&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2015.09.012

DO - 10.1016/j.jacc.2015.09.012

M3 - Article

C2 - 26564599

AN - SCOPUS:84946748049

VL - 66

SP - 2211

EP - 2213

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 20

ER -